⌘K
Loading ticker…
As of 2026-08-24, Caris Life Sciences, Inc. Common Stock (CAI) has a 3-month relative strength percentile of 96 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 59. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.6%, relative volume 1.09×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
CAI is held by 16 ETFs as of May 2026. Top owner: VONG at 0.00% weight, $1M notional. Top 3 carry $4M.
Held by 49 ETFs · $169M across latest filings · largest weight 2.44% (IDNA).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VONGVanguard Russell 1000 Growth ETF | 0.00% | $1M | — |
| ONEQ | 0.01% | $1M | — |
| GNOM | 2.03% | $1M | new |
| FMED | 1.71% | $702K | +0.39 pp |
| EQAL | 0.08% | $621K | +0.01 pp |
| VONVVanguard Russell 1000 Value ETF | 0.00% | $487K | — |
| ESGV | 0.00% | $344K | new |
| VONEVanguard Russell 1000 ETF | 0.00% | $267K | — |
| PTL | 0.03% | $263K | — |
| IBBQ | 0.37% | $252K | −0.05 pp |
Showing 10 of 16 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CAI Jan avg: -14.16% median: -14.16% win: 0% σ: 0.00% n: 1 2025-06-20 → 2026-07-31 | CAI Feb avg: -13.04% median: -13.04% win: 0% σ: 0.00% n: 1 2025-06-20 → 2026-07-31 | CAI Mar avg: -11.22% median: -11.22% win: 0% σ: 0.00% n: 1 2025-06-20 → 2026-07-31 | CAI Apr avg: 6.26% median: 6.26% win: 100% σ: 0.00% n: 1 2025-06-20 → 2026-07-31 | CAI May avg: -12.00% median: -12.00% win: 0% σ: 0.00% n: 1 2025-06-20 → 2026-07-31 | CAI Jun avg: 1.00% median: 1.00% win: 50% σ: 7.89% n: 2 2025-06-20 → 2026-07-31 | CAI Jul avg: -3.49% median: -3.49% win: 50% σ: 12.13% n: 2 2025-06-20 → 2026-07-31 | CAI Aug avg: 36.72% median: 36.72% win: 100% σ: 0.00% n: 1 2025-06-20 → 2026-07-31 (current) | CAI Sep avg: -21.20% median: -21.20% win: 0% σ: 0.00% n: 1 2025-06-20 → 2026-07-31 | CAI Oct avg: -0.56% median: -0.56% win: 0% σ: 0.00% n: 1 2025-06-20 → 2026-07-31 | CAI Nov avg: -15.13% median: -15.13% win: 0% σ: 0.00% n: 1 2025-06-20 → 2026-07-31 | CAI Dec avg: 5.68% median: 5.68% win: 100% σ: 0.00% n: 1 2025-06-20 → 2026-07-31 |